Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Bin ZhuLap Ah TseDifei WangHela KokaTongwu ZhangMustapha AbubakarPriscilla LeeFeng WangCherry WuKoon Ho TsangWing-Cheong ChanSze Hong LawMengjie LiWentao LiSuyang WuZhiguang LiuBixia HuangHan ZhangEric TangZhengyan KanSoohyeon LeeYeon Hee ParkSeok Jin NamMingyi WangXuezheng SunKristine JonesBin ZhuAmy HutchinsonBelynda HicksLudmila Prokunina-OlssonJianxin ShiMontserrat Garcia-ClosasStephen ChanockXiaohong R YangPublished in: Breast cancer research : BCR (2019)
Our findings suggest that immune gene expression and associated genomic features could be useful to further stratify luminal BC beyond the current luminal A/B classification and a subset of luminal BC patients may benefit from checkpoint immunotherapy, at least in Asian populations.